期刊
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
卷 22, 期 3, 页码 355-365出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.beha.2009.04.001
关键词
BCR-ABL; real time PCR; international scale; minimal residual disease
类别
资金
- European LeukemiaNet
- UK Department of Health
- Novartis through the European Treatment and Outcome Study (EUTOS)
- Bristol-Myers Squibb
Molecular monitoring of chronic myeloid leukaemia (CIVIL) patients by real time quantitative reverse transcriptase PCR (RQ-PCR) is of clinical value, but the use of diverse laboratory protocols and units of measurement make it difficult to compare results between and sometimes within centres. This review explores the intrinsic difficulties in standardising the RQ-PCR analysis, summarises the progress that has been made following the proposal for a new International Scale for BCR-ABL measurement and discusses how further improvements are likely to be made. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据